Crown Electrokinetics Corp.

CRKN Basic Materials Specialty Chemicals

Crown Electrokinetics Corp.’s revenue for fiscal 2024 (year ended December 2024) was $19.7 million, up 12,776.5% from fiscal 2023. In the quarter to March 2025, revenue grew 306.5%, EPS grew 99.8% and free cash flow fell 362.5%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

0.00 0.01 −100.00%
Market cap
$5.8M
P/E
0.0×
Fwd P/E
0.3×
Dividend yield
—
F-score
n/a
Altman Z
52.49
Beneish M
n/a
Dividend safety
n/a
Mar '25 Dec '24 Sep '24 Jun '24 Older periods
ROE
(195.09%) (241.21%) (317.74%) (416.46%)

+8 more TTM periods

ROA
(142.30%) (145.89%) (204.75%) (197.36%)
ROIC
(134.95%) (163.47%) (186.21%) (232.29%)
Return on Tangible Assets
(108.10%) (155.75%) (390.70%) (431.17%)
Average Days of Receivables
82.75 99.23 132.02 223.97
Free Cash Flow per Share
(20.48) (0.41) (619.33) (1,550.85)
Free Cash Flow
(34.26) (24.33) (19.32) (18.14)
Capital Expenditures
(7.74) (6.14) (3.21) (1.52)
Other line items
Cash ROIC
(58.12%) (66.42%) (145.07%) (138.85%)
Accounts Receivable Turnover
7.62 7.24 5.29 3.24
Accounts Payable Turnover
7.71 5.89 4.28 3.41
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
57.45 97.21 119.50 117.34
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
0.00 0.00 0.00 0.00
Research and Development Expense of Revenue
16.92% 17.09% 29.80% 69.27%
Selling, General and Administrative Expense of Revenue
118.97% 101.75% 125.46% 243.95%
Share Based Compensation of Revenue
32.54% 26.65% 35.99% 51.73%
Interest Coverage
473.77 (24.27) (6.17) (3.21)
Operating CF/Net income
0.71 0.56 0.53 0.60
Depreciation/Fixed assets
0.27 0.38 1.00 2.29
Capex/Depreciation
(3.04) (1.92) (0.60) (0.22)
Revenue per Share
13.03 0.33 431.44 466.75
Operating CF per Share
(15.85) (0.31) (516.38) (1,420.77)
Capex per Share
(4.63) (0.10) (102.95) (130.09)
Capex to Sales
0.36 0.31 0.24 0.28

Fold the line items

Columns are period end dates